Select your language/region

News & events

Regulatory press release

2024/11/07

NOTICE OF EXTRAORDINARY GENERAL MEETING IN Q-LINEA AB (PUBL)

Regulatory press release

2024/11/05

Interim report 1 January - 30 September 2024
Growing pipeline in the USThird quarter: 1 July – 30 September 2024Net sales amounted to SEK 0.6 million (3.0).The...
Read more >

Regulatory press release

2024/11/05

Q-linea resolves to carry out a rights issue of approximately SEK 225 million and enters into an agreement for a bridge loan facility of approximately SEK 40 million
Q-linea AB (publ) (”Q-linea” or the “Company”) announces that the board of directors today has resolved to carry out...
Read more >

Press release

2024/10/29

Q-linea to participate in a multi-site public tender in Italy
Q-linea AB (publ) (OMX: QLINEA) today announces participation in the upcoming 5-year Tender at ASL Napoli 2 Nord for...
Read more >

Press release

2024/10/29

ASTar® evaluation begins at a US National Cancer Institute-designated cancer center

Regulatory press release

2024/10/28

Changed date for Interim Report
The board of Q-linea AB (publ) ("Q-linea" or the "Company") has decided to change the date for the publication...
Read more >

Press release

2024/10/25

Q-linea receives request for a 3-year contract at prominent Hospital in Milan, Italy

Press release

2024/10/24

Two UK commercial evaluations closing successfully
Q-linea AB (publ) (OMX: QLINEA) today announces that Pro-lab Diagnostics, its exclusive distribution partner for the UK, has closed...
Read more >

Press release

2024/10/24

Q-linea announces the initiation of a DOOR MAT study at a large US academic medical center

Press release

2024/10/24

Invitation to presentation of Q-linea’s Interim report Q3-2024 on October 31, 2024
Load more